A discussion about pioglitazone Actos as a potential therapy for PKD

PKD Foundation Chief Scientific Officer David Baron, Ph.D., discusses the new study looking at pioglitazone (Actos) as a potential drug therapy for PKD. Guest speaker Bonnie Blazer-Yost, Ph.D., principal investigator for the study, joins the discussion too.

Originally aired: October, 2015